123 related articles for article (PubMed ID: 12210420)
21. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
Purcell DF
Dev Biol (Basel); 2001; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.
Barsov EV; Hughes SH
J Virol; 1996 Jun; 70(6):3922-9. PubMed ID: 8648729
[TBL] [Abstract][Full Text] [Related]
24. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
Lee ES; Jin SY; Kang BK; Jung YT
J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
[TBL] [Abstract][Full Text] [Related]
25. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
[TBL] [Abstract][Full Text] [Related]
26. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
27. In vitro testing of a potential retroviral vector for producing transgenic livestock.
Squire KR; Embretson JE; First NL
Am J Vet Res; 1989 Aug; 50(8):1423-7. PubMed ID: 2551203
[TBL] [Abstract][Full Text] [Related]
28. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
Palmer MT; McPherson S; Morrow CD
Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
[TBL] [Abstract][Full Text] [Related]
29. Intracellular assembly and budding of the Murine Leukemia Virus in infected cells.
Houzet L; Gay B; Morichaud Z; Briant L; Mougel M
Retrovirology; 2006 Feb; 3():12. PubMed ID: 16472393
[TBL] [Abstract][Full Text] [Related]
30. Early detection of a two-long-terminal-repeat junction molecule in the cytoplasm of recombinant murine leukemia virus-infected cells.
Serhan F; Penaud M; Petit C; Leste-Lasserre T; Trajcevski S; Klatzmann D; Duisit G; Sonigo P; Moullier P
J Virol; 2004 Jun; 78(12):6190-9. PubMed ID: 15163712
[TBL] [Abstract][Full Text] [Related]
31. Stable integration of a functional shRNA expression cassette into the murine leukemia virus genome.
Sliva K; Schnierle BS
Virology; 2006 Jul; 351(1):218-25. PubMed ID: 16631223
[TBL] [Abstract][Full Text] [Related]
32. Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection.
Walker SJ; Pizzato M; Takeuchi Y; Devereux S
J Virol; 2002 Jul; 76(14):6909-18. PubMed ID: 12072492
[TBL] [Abstract][Full Text] [Related]
33. Human primary T lymphocytes have a low capacity to amplify MLV-based amphotropic RCR and the virions produced are largely noninfectious.
Ebeling SB; Simonetti ER; Borst HP; Blok A; Schelen AM; Braakman E; Ederveen J; Hagenbeek A
Gene Ther; 2003 Oct; 10(21):1800-6. PubMed ID: 12960969
[TBL] [Abstract][Full Text] [Related]
34. No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses.
Amit M; Winkler ME; Menke S; Brüning E; Büscher K; Denner J; Haverich A; Itskovitz-Eldor J; Martin U
Stem Cells; 2005; 23(6):761-71. PubMed ID: 15917472
[TBL] [Abstract][Full Text] [Related]
35. R7, a spontaneous mutant of Moloney murine sarcoma virus 124 with three direct repeats and an in-frame truncated gag-mos gene, induces brain lesions.
Yuen PH; Kwak YT
Virology; 1997 Sep; 236(1):213-8. PubMed ID: 9299634
[TBL] [Abstract][Full Text] [Related]
36. Murine leukemia virus clearance by flocculation and microfiltration.
Akeprathumchai S; Han B; Wickramasinghe SR; Carlson JO; Czermak P; Preibeta K
Biotechnol Bioeng; 2004 Dec; 88(7):880-9. PubMed ID: 15515166
[TBL] [Abstract][Full Text] [Related]
37. Phosphate depletion enhances the stability of the amphotropic murine leukemia virus receptor mRNA.
Chien ML; O'Neill E; Garcia JV
Virology; 1998 Jan; 240(1):109-17. PubMed ID: 9448695
[TBL] [Abstract][Full Text] [Related]
38. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
[TBL] [Abstract][Full Text] [Related]
39. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
40. Amphotropic murine leukaemia virus envelope protein is associated with cholesterol-rich microdomains.
Beer C; Pedersen L; Wirth M
Virol J; 2005 Apr; 2():36. PubMed ID: 15840168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
